MTNB - Matinas BioPharma Holdings, Inc.
0.601
0.025 4.160%
Share volume: 23,737
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$0.58
0.03
0.04%
View ratios
| Fiscal Date | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 11-13-2024 | 05-15-2025 | 08-14-2025 | 11-10-2025 | |
| Assets | |||||
| Total Assets | 20.577 M | 12.035 M | 11.424 M | 9.695 M | |
| Current Assets | 11.741 M | 7.547 M | 7.268 M | 5.653 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 500.000 K | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 10.295 M | 6.924 M | 6.525 M | 5.435 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 1.648 M | 450.000 K | 158.000 K | 156.000 K | |
| Other Assets | 7.188 M | 4.038 M | 3.998 M | 3.886 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||
| Total Liabilities and shareholders’ equity | 20.577 M | 12.035 M | 11.424 M | 9.695 M | |
| Total liabilities | 4.798 M | 5.765 M | 3.749 M | 3.235 M | |
| Total current liabilities | 2.124 M | 2.255 M | 1.784 M | 1.495 M | |
| Accounts Payable | 349.000 K | 282.000 K | 167.000 K | 80.000 K | |
| Other liabilities | 2.319 M | 3.242 M | 1.697 M | 1.472 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 2.319 M | 3.242 M | 1.697 M | 1.472 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 15.779 M | 6.270 M | 7.675 M | 6.460 M | |
| Common stock | 207.170 M | 207.750 M | 214.400 M | 215.335 M | |
| Retained earnings | -191.391 M | -201.480 M | -206.725 M | -208.875 M |